Guiqiang Wang

jiangxi normal university

H指数:30

被引数:2,917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Biomarker Combinations and Novel Surveillance Strategies: A "Traffic Light" Approach and Resource Optimization

生物标志物组合与新型监测策略：一种“红绿灯”方法及资源优化

Gastroenterology

IF25.1

2026-04-290

PRE

Beyond steroid-dependent care: can TNF blockade evolve into a precision therapy for autoimmune hepatitis?

超越类固醇依赖性治疗：肿瘤坏死因子阻断疗法能否发展为自身免疫性肝炎的精准疗法？

Journal of Hepatology

IF33

2026-04-290

PRE

Serum sIL-2R Predicts Significant Histological Disease in Indeterminate Phase Chronic Hepatitis B

血清sIL-2R预测慢性乙型肝炎不确定期的显著组织学病变

International Journal of Infectious Diseases

IF4.3

2026-03-190

OAAI

Nitrogen addition reduces alpine grassland stability via enhanced temporal synchrony and population variability

氮添加通过增强时间同步性和种群变异性降低高寒草原稳定性

Oecologia

IF2.3

2026-02-060

PRE

Effects of grazing intensity on photosynthetic carbon allocation and transport in the typical grassland of Inner Mongolia

Plant and Soil

IF4.1

2026-01-190

PRE

Conservation genomics highlights the urgency of protecting Indo-Pacific humpback dolphins (Sousa chinensis) in Chinese waters

保护基因组学突显了在中国水域保护印度洋-太平洋驼背鲸（Sousa chinensis）的紧迫性。

Science China Life Sciences

IF9.5

2026-01-050

PRE

Do the therapeutic vaccines hold hope for the treatment of hepatitis B?

治疗性疫苗对于乙型肝炎的治疗有希望吗？

Hepatology International

IF6.1

2025-09-270

OAAI

Functional shift in soil microbiome with decline in photosynthetic carbon input signifies rapid decrease of soil organic carbon during alpine grassland degradation

随着光合碳输入的减少，土壤微生物组的功能转变意味着高寒草地退化过程中土壤有机碳的快速减少

BIOLOGY AND FERTILITY OF SOILS

IF5.6

2025-03-010

PRE

Assessing pricing and affordability of HBV treatment in Asia-Pacific region: a barrier to elimination

评估亚太地区HBV治疗的定价和负担能力: 消除障碍

HEPATOLOGY INTERNATIONAL

IF6.1

2025-02-030

OAAI

Dose-response relationship between serum N-glycan markers and liver fibrosis in chronic hepatitis B

HEPATOLOGY INTERNATIONAL

IF6.1

2024-07-171

OAAI

Expert consensus on the diagnosis and treatment of end-stage liver disease complicated by infections

HEPATOLOGY INTERNATIONAL

IF6.1

2024-03-095

Immune Dysregulation in SARS-CoV-2 patients coinfected with Mycobacterium tuberculosis (Mtb) or HIV in China

BMC PUBLIC HEALTH

IF3.6

2024-02-221

OAAI

Burden of infectious diseases and bacterial antimicrobial resistance in China: a systematic analysis for the global burden of disease study 2019

中国传染病负担与细菌耐药性: 全球疾病负担研究2019的系统分析

LANCET REGIONAL HEALTH-WESTERN PACIFIC

IF8.1

2024-02-0121

OAAI

Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)

慢性乙型肝炎防治指南 (2022版)

clinical and translational gastroenterology

IF4.2

2023-08-15176

OAAI

Global, regional, and national burdens of cirrhosis in children and adolescents aged under 19 years from 1990 to 2019

HEPATOLOGY INTERNATIONAL

IF6.1

2023-04-2612

OAAI

Safety and immunogenicity of a bivalent SARS-CoV-2 recombinant protein vaccine, SCTV01C in unvaccinated adults: A randomized, double-blinded, placebo-controlled, phase I clinical trial

JOURNAL OF INFECTION

IF11.9

2023-02-016

OAAI

Global Patterns and Trends in Total Burden of Hepatitis B from 1990 to 2019 and Predictions to 2030

clinical epidemiology

IF3.2

2022-12-0117

OAAI

Serum HBV RNA as a predictor of virological response in treatment-naive chronic HBeAg-positive HBV-infected patients with normal alanine aminotransferase

CHINESE MEDICAL JOURNAL

IF7.3

2022-10-052

OAAI

A new uniform framework of source attribution in forensic science

HUMANITIES & SOCIAL SCIENCES COMMUNICATIONS

IF3.6

2022-08-080

Diagnostic and Predictive Values of Ferroptosis-Related Genes in Child Sepsis

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-06-3028

OAAI

Guiqiang Wang

个人简介

教育背景

工作经历

荣誉奖项

研究方向